MAP3K1 and breast cancer: Importantly, the suppression of P-gp by miR-302 was reversed by MEKK1 overexpression, suggesting that miR-302 cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-gp by targeting MEKK1 of ERK pathway.